- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Synta Pharmaceuticals Corp+ Add to Watchlist
SNTA:US2.2200 USD 0.0500 2.20%
As of 20:10:00 ET on 05/26/2015.
Company Profile for Synta Pharmaceuticals Corp (SNTA)
Synta Pharmaceuticals Corp. is a biopharmaceutical company developing small-molecule drugs for inflammatory diseases, cancer, and diabetes. The Company has drug candidates in human clinical trials and additional programs in preclinical studies.
Synta Pharmaceuticals Corp
Key Executives for Synta Pharmaceuticals Corp (SNTA)
|Chen SchorPresident/CEO||Marc R SchneebaumSenior VP/CFO|
|Vojo VukovicSenior VP/Chief Medical Ofcr||Arthur McMahon "Art"Senior VP:People Operations|
|Wendy E RiederVP/Secretary/Genral Counsel||Mindy S KohlAssociate Dir:Investor Relations|